Differentiation of pluripotent stem cells into retinal pigmented epithelium

Cell-Based Therapy for Retinal Degenerative Disease

Volumn 53, Issue , 2014, Pages 81-96

  Croze, Roxanne H ^a   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925879638     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000357361     Document Type: Chapter

References (140)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS: Age-related macular degeneration - emerging pathogenetic and therapeutic concepts. Ann Med 2006; 38: 450-471.
2. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB: Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011; 129: 75-80.
3. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR, Beckman Initiative for Macular Research Classification C: clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844-851.
4. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE: Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114: 253-262.
5. Cho H, Shah CP, Weber M, Heier JS: Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab. Br J Ophthalmol 2013; 97: 1032-1035.
6. Bakall B, Folk JC, Boldt HC, Sohn EH, Stone EM, Russell SR, Mahajan VB: Aflibercept therapy for exudative agerelated macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol 2013; 156:15-22 e11.
7. Kaiser PK: Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline. Ophthalmology 2013; 120:S11-S15.
8. Curcio CA, Medeiros NE, Millican CL: Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996; 37: 1236-1249.
9. Young RW: Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31: 291-306.
10. Buschini E, Piras A, Nuzzi R, Vercelli A: Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 2011; 95: 14-25.
11. Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS: New approaches and potential treatments for dry agerelated macular degeneration. Arq Bras Oftalmol 2012; 75: 71-76.
12. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P: RPE transplantation and its role in retinal disease. Prog Retin Eye Res 2007; 26: 598-635.
13. Leveziel N, Tilleul J, Puche N, Zerbib J, Laloum F, Querques G, Souied EH: Genetic factors associated with age-related macular degeneration. Ophthalmologica. Int J Ophthalmol 2011; 226: 87-102.
14. Melville H, Carpiniello M, Hollis K, Staffaroni A, Golestaneh N: Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration. J Transl Med 2013; 11:53.
15. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA: Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-421.
16. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Group, AMDGCS, Hageman GS, Dean M, Allikmets R: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-462.
17. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL: Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007; 16: 1986-1992.
18. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB: C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PloS One 2008; 3:e2199.
19. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM: Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007; 39: 1200-1201.
20. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT; Genetic Factors in AMD Study Group: Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007; 357: 553-561.
21. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
22. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH: The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004; 45: 1311-1315.
23. Chen W, Stambolian D, Edwards AO, Branham KE, et al: Genetic variants near TIMP3 and high-density lipoproteinassociated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010; 107: 7401-7406.
24. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA: Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006; 47: 329-335.
25. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J: HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992.
26. Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, Maguire AM, Bennett J, Stone EM, Jacobson SG: Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 2004; 13: 525-534.
27. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M: Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805-1807.
28. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF: An integrated hypothesis that considers drusen as biomarkers of immunemediated processes at the RPE-Bruch's membrane interface in aging and agerelated macular degeneration. Progr Retin Eye Res 2001; 20: 705-732.
29. Curcio CA, Messinger JD, Sloan KR, McGwin G, Medeiros NE, Spaide RF: Subretinal drusenoid deposits in nonneovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 2013; 33: 265-276.
30. Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO: Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in age-related macular degeneration. Exp Eye Res 2002; 74: 141-154.
31. Del Priore LV, Kuo YH, Tezel TH: Agerelated changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 2002; 43: 3312-3318.
32. Dunaief JL, Dentchev T, Ying GS, Milam AH: The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 2002; 120: 1435-1442.
33. Bharti K, Nguyen MT, Skuntz S, Bertuzzi S, Arnheiter H: The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res 2006; 19: 380-394.
34. Strauss O: The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845-881.
35. Deng WT, Dinculescu A, Li Q, Boye SL, Li J, Gorbatyuk MS, Pang J, Chiodo VA, Matthes MT, Yasumura D, Liu L, Alkuraya FS, Zhang K, Vollrath D, LaVail MM, Hauswirth WW: Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci 2012; 53: 1895-1904.
36. Hufnagel RB, Ahmed ZM, Correa ZM, Sisk RA: Gene therapy for Leber congenital amaurosis: advances and future directions. Graefes Arch Clin Exp Ophthalmol 2012; 250: 1117-1128.
37. Singh R, Shen W, Kuai D, Martin JM, Guo X, Smith MA, Perez ET, Phillips MJ, Simonett JM, Wallace KA, Verhoeven AD, Capowski EE, Zhang X, Yin Y, Halbach PJ, Fishman GA, Wright LS, Pattnaik BR, Gamm DM: iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 2013; 22: 593-607.
38. Age-Related Eye Disease Study 2 Research Group: Lutein/zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309: 2005-2015.
39. Morgan JI, Hunter JJ, Masella B, Wolfe R, Gray DC, Merigan WH, Delori FC, Williams DR: Light-induced retinal changes observed with high-resolution autofluorescence imaging of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008; 49: 3715-3729.
40. Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauve Y, Lanza R: Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006; 8: 189-199.
41. Coffey PJ, Girman S, Wang SM, Hetherington L, Keegan DJ, Adamson P, Greenwood J, Lund RD: Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci 2002; 5: 53-56.
42. Wang S, Lu B, Girman S, Holmes T, Bischoff N, Lund RD: Morphological and functional rescue in RCS rats after RPE cell line transplantation at a later stage of degeneration. Invest Ophthalmol Vis Sci 2008; 49: 416-421.
43. Lund RD, Adamson P, Sauve Y, Keegan DJ, Girman SV, Wang S, Winton H, Kanuga N, Kwan AS, Beauchene L, Zerbib A, Hetherington L, Couraud PO, Coffey P, Greenwood J: Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc Natl Acad Sci USA 2001; 98: 9942-9947.
44. Wang S, Girman S, Lu B, Bischoff N, Holmes T, Shearer R, Wright LS, Svendsen CN, Gamm DM, Lund RD: Longterm vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci 2008; 49: 3201-3206.
45. Sauve Y, Girman SV, Wang S, Keegan DJ, Lund RD: Preservation of visual responsiveness in the superior colliculus of RCS rats after retinal pigment epithelium cell transplantation. Neuroscience 2002; 114: 389-401.
46. Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA: Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol 2005; 123: 935-938.
47. Rowland TJ, Buchholz DE, Clegg DO: Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol 2012; 227: 457-466.
48. Binder S, Stanzel BV, Krebs I, Glittenberg C: Transplantation of the RPE in AMD. Progr Retin Eye Res 2007; 26: 516-554.
49. Gullapalli VK, Khodair MA, Wang H, Sugino IK, Madreperla S, Zarbin MA: Retinal pigment epithelium and photoreceptor transplantation frontiers; in Ryan SJ (ed): Retina. Amsterdam, Elsevier, 2013.
50. Bharti K, Miller SS, Arnheiter H: The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res 2011; 24: 21-34.
51. Stern JH, Temple S: Stem cells for retinal replacement therapy. Neurotherapeutics 2011; 8: 736-743.
52. Sudhakar J, Natarajan S, Parikumar P, Shanmugam M, Senthikumar R, Green DW, Abraham SJK: Choice of cell source in cell-based therapies for retinal damage due to age-related macular degeneration: a review. J Ophthalmol 2013: 2013; 465169.
53. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
54. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
55. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
56. Zhao T, Zhang ZN, Rong Z, Xu Y: Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-215.
57. Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS: Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013; 12: 407-412.
58. Boyd AS, Rodrigues NP, Lui KO, Fu X, Xu Y: Concise review: immune recognition of induced pluripotent stem cells. Stem Cells 2012; 30: 797-803.
59. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K: Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
60. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA: Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
61. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC: Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 2011; 6: 78-88.
62. Solanki A, Lee KB: A step closer to complete chemical reprogramming for generating iPS cells. Chembiochem 2010; 11: 755-757.
63. Yu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y: Efficient feeder-free episomal reprogramming with small molecules. PloS One 2011; 6:e17557.
64. Gong J, Sagiv O, Cai H, Tsang SH, Del Priore LV: Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp Eye Res 2008; 86: 957-965.
65. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A, Lundh P, Semo M, Ahmado A, Gias C, da Cruz L, Moore H, Andrews P, Walsh J, Coffey P: Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 2008; 214: 347-361.
66. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO: Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009; 27: 2427-2434.
67. Carr AJ, Vugler A, Lawrence J, Chen LL, Ahmado A, Chen FK, Semo M, Gias C, da Cruz L, Moore HD, Walsh J, Coffey PJ: Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 2009; 15: 283-295.
68. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R: Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27: 2126-2135.
69. Meyer JS, Shearer RL, Capowski, EE, Wright LS, Wallace KA, McMillan EL, Zhang SC, Gamm DM: Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009; 106: 16698-16703.
70. Osakada F, Ikeda H, Sasai Y, Takahashi M: Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc 2009; 4: 811-824.
71. Osakada F, Jin ZB, Hirami Y, Ikeda H, Danjyo T, Watanabe K, Sasai Y, Takahashi M: In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009; 122: 3169-3179.
72. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N, Khaner H, Smith Y, Wiser O, Gropp M, Cohen MA, Even-Ram S, Berman-Zaken Y, Matzrafi L, Rechavi G, Banin E, Reubinoff B: Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009; 5: 396-408.
73. Liao JL, Yu J, Huang K, Hu J, Diemer T, Ma Z, Dvash T, Yang XJ, Travis GH, Williams DS, Bok D, Fan G: Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet 2010; 19: 4229-4238.
74. Nistor G, Seiler MJ, Yan F, Ferguson D, Keirstead HS: Three-dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells. J Neurosci Methods 2010; 190: 63-70.
75. Buchholz DE, Pennington BO, Croze RH, Himan CR, Coffey PJ, Clegg DO: Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med 2013; 2: 384-393.
76. Rowland TJ, Blaschke AJ, Buchholz DE, Hikita ST, Johnson LV, Clegg DO: Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med 2013; 7: 642-653.
77. Song MK, Lui GM: Propagation of fetal human RPE cells: preservation of original culture morphology after serial passage. J Cell Physiol 1990; 143: 196-203.
78. Campochiaro PA, Hackett SF: Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components. Exp Eye Res 1993; 57: 539-547.
79. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R: Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004; 6: 217-245.
80. Maruotti J, Wahlin K, Gorrell D, Bhutto I, Lutty G, Zack DJ: A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med 2013; 2: 341-354.
81. Carr AJ, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL, Buchholz DE, Ahmado A, Semo M, Smart MJ, Hasan S, da Cruz L, Johnson LV, Clegg DO, Coffey PJ: Protective effects of human iPSderived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PloS One 2009; 4:e8152.
82. Li Y, Tsai YT, Hsu CW, Erol D, Yang J, Wu WH, Davis RJ, Egli D, Tsang SH: Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 2012; 18: 1312-1319.
83. Ukrohne TU, Westenskow PD, Kurihara T, Friedlander DF, Lehmann M, Dorsey AL, Li W, Zhu S, Schultz A, Wang J, Siuzdak G, Ding S, Friedlander M: Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med 2012; 1: 96-109.
84. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, Akaike A, Sasai Y, Takahashi M: Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26: 215-224.
85. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, Yoshimura N, Takahashi M: Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126-131.
86. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R: Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010; 28: 704-712.
87. Mekala SR, Vauhini V, Nagarajan U, Maddileti S, Gaddipati S, Mariappan I: Derivation, characterization and retinal differentiation of induced pluripotent stem cells. J Biosci 2013; 38: 123-134.
88. Williams LA, Davis-Dusenbery BN, Eggan KC: SnapShot: directed differentiation of pluripotent stem cells. Cell 2012; 149:1174.
89. Munoz-Sanjuan I, Brivanlou AH: Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci 2002; 3: 271-280.
90. Zahabi A, Shahbazi E, Ahmadieh H, Hassani SN, Totonchi M, Taei A, Masoudi N, Ebrahimi M, Aghdami N, Seifinejad A, Mehrnejad F, Daftarian N, Salekdeh GH, Baharvand H: A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012; 21: 2262-2272.
91. Zhu Y, Carido M, Meinhardt A, Kurth T, Karl MO, Ader M, Tanaka EM: Threedimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PloS One 2013; 8:e54552.
92. Enzmann V, Howard RM, Yamauchi Y, Whittemore SR, Kaplan HJ: Enhanced induction of RPE lineage markers in pluripotent neural stem cells engrafted into the adult rat subretinal space. Invest Ophthalmol Vis Sci 2003; 44: 5417-5422.
93. Vossmerbaeumer U, Ohnesorge S, Kuehl S, Haapalahti M, Kluter H, Jonas JB, Thierse HJ, Bieback K: Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy 2009; 11: 177-188.
94. Huang C, Zhang J, Ao M, Li Y, Zhang C, Xu Y, Li X, Wang W: Combination of retinal pigment epithelium cell-conditioned medium and photoreceptor outer segments stimulate mesenchymal stem cell differentiation toward a functional retinal pigment epithelium cell phenotype. J Cell Biochem 2012; 113: 590-598.
95. Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, McInnes RR, Arsenijevic Y, van der Kooy D: Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci USA 2004; 101: 15772-15777.
96. Cicero SA, Johnson D, Reyntjens S, Frase S, Connell S, Chow LM, Baker SJ, Sorrentino BP, Dyer MA: Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Proc Natl Acad Sci USA 2009; 106: 6685-6690.
97. Salero E, Blenkinsop TA, Corneo B, Harris A, Rabin D, Stern JH, Temple S: Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 2012; 10: 88-95.
98. Zhang K, Liu GH, Yi F, Montserrat N, Hishida T, Rodriguez Esteban C, Izpisua Belmonte JC: Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell 2013, Epub ahead of print.
99. Pera MF: Stem cells: the dark side of induced pluripotency. Nature 2011; 471: 46-47.
100. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch, R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ: Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
101. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K: Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63-67.
102. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C, Lundin K, Mikkola M, Trokovic R, Peitz M, Brustle O, Bazett-Jones DP, Alitalo K, Lahesmaa R, Nagy A, Otonkoski T: Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58-62.
103. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget, J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471: 68-73.
104. Hu Q, Friedrich AM, Johnson LV, Clegg DO: Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010; 28: 1981-1991.
105. Toivonen S, Ojala M, Hyysalo A, Ilmarinen T, Rajala K, Pekkanen-Mattila M, Aanismaa R, Lundin K, Palgi J, Weltner J, Trokovic R, Silvennoinen O, Skottman H, Narkilahti S, Aalto-Setala K, Otonkoski T: Comparative analysis of targeted differentiation of human induced pluripotent stem cells ( hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines. Stem Cells Transl Med 2013; 2: 83-93.
106. Lamba DA, Reh TA: Microarray characterization of human embryonic stem cell-derived retinal cultures. Invest Ophthalmol Vis Sci 2011; 52: 4897-4906.
107. Frisch SM, Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol 1997; 9: 701-706.
108. Hynes SR, Lavik EB: A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol 2010; 248: 763-778.
109. Del Priore LV, Tezel TH, Kaplan HJ: Maculoplasty for age-related macular degeneration: reengineering Bruch's membrane and the human macula. Prog Retin Eye Res 2006; 25: 539-562.
110. Capeans C, Pineiro A, Pardo M, Sueiro-Lopez C, Blanco MJ, Dominguez F, Sanchez-Salorio M: Amniotic membrane as support for human retinal pigment epithelium (RPE) cell growth. Acta Ophthalmol Scand 2003; 81: 271-277.
111. Ohno-Matsui K, Ichinose S, Nakahama K, Yoshida T, Kojima A, Mochizuki M, Morita I: The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis 2005; 11: 1-10.
112. Ohno-Matsui K, Mori K, Ichinose S, Sato T, Wang J, Shimada N, Kojima A, Mochizuki M, Morita I: In vitro and in vivo characterization of iris pigment epithelial cells cultured on amniotic membranes. Mol Vis 2006; 12: 1022-1032.
113. Singhal S, Vemuganti GK: Primary adult human retinal pigment epithelial cell cultures on human amniotic membranes. Ind J Ophthalmol 2005; 53: 109-113.
114. Singh S, Woerly S, McLaughlin BJ: Natural and artificial substrates for retinal pigment epithelial monolayer transplantation. Biomaterials 2001; 22: 3337-3343.
115. Lee CJ, Huie P, Leng T, Peterman MC, Marmor MF, Blumenkranz MS, Bent SF, Fishman HA: Microcontact printing on human tissue for retinal cell transplantation. Arch Ophthalmol 2002; 120: 1714-1718.
116. Lee CJ, Fishman HA, Bent SF: Spatial cues for the enhancement of retinal pigment epithelial cell function in potential transplants. Biomaterials 2007; 28: 2192-2201.
117. Ho TC, Del Priore LV: Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest Ophthalmol Vis Sci 1997; 38: 1110-1118.
118. Tezel TH, Del Priore LV, Kaplan HJ: Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci 2004; 45: 3337-3348.
119. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM: Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 2008; 15: 88-99.
120. Ho TC, Del Priore LV, Kaplan HJ: En bloc transfer of extracellular matrix in vitro. Curr Eye Res 1996; 15: 991-997.
121. Tezel TH, Del Priore LV: Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 1997; 235: 41-47.
122. Bhatt NS, Newsome DA, Fenech T, Hessburg TP, Diamond JG, Miceli MV, Kratz KE, Oliver PD: Experimental transplantation of human retinal pigment epithelial cells on collagen substrates. Am J Ophthalmol 1994; 117: 214-221.
123. Huang JC, Ishida M, Hersh P, Sugino IK, Zarbin MA: Preparation and transplantation of photoreceptor sheets. Curr Eye Res 1998; 17: 573-585.
124. Imai H, Honda S, Kondo N, Ishibashi K, Tsukahara Y, Negi A: The upregulation of angiogenic gene expression in cultured retinal pigment epithelial cells grown on type I collagen. Curr Eye Res 2007; 32: 903-910.
125. Lu JT, Lee CJ, Bent SF, Fishman HA, Sabelman EE: Thin collagen film scaffolds for retinal epithelial cell culture. Biomaterials 2007; 28: 1486-1494.
126. Oganesian A, Gabrielian K, Ernest JT, Patel SC: A new model of retinal pigment epithelium transplantation with microspheres. Arch Ophthalmol 1999; 117: 1192-1200.
127. Giordano GG, Thomson RC, Ishaug SL, Mikos AG, Cumber S, Garcia CA, Lahiri-Munir D: Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 1997; 34: 87-93.
128. Lu L, Garcia CA, Mikos AG: Retinal pigment epithelium cell culture on thin biodegradable poly( DL -lactic-co-glycolic acid) films. J Biomater Sci Polym Ed 1998; 9: 1187-1205.
129. Lu L, Yaszemski MJ, Mikos AG: Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials 2001; 22: 3345-3355.
130. Thomson RC, Giordano GG, Collier JH, Ishaug SL, Mikos AG, Lahiri-Munir D, Garcia CA: Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials 1996; 17: 321-327.
131. Thomson HA, Treharne AJ, Backholer LS, Cuda F, Grossel MC, Lotery AJ: Biodegradable poly(alpha-hydroxy ester) blended microspheres as suitable carriers for retinal pigment epithelium cell transplantation. J Biomed Mater Res A 2010; 95: 1233-1243.
132. Hadlock T, Singh S, Vacanti JP, McLaughlin BJ: Ocular cell monolayers cultured on biodegradable substrates. Tissue Eng 1999; 5: 187-196.
133. Lim JM, Byun S, Chung S, Park TH, Seo JM, Joo CK, Chung H, Cho DI: Retinal pigment epithelial cell behavior is modulated by alterations in focal cellsubstrate contacts. Invest Ophthalmol Vis Sci 2004; 45: 4210-4216.
134. Tezcaner A, Bugra K, Hasirci V: Retinal pigment epithelium cell culture on surface modified poly(hydroxybutyrate-co-hydroxyvalerate) thin films. Biomaterials 2003; 24: 4573-4583.
135. Williams RL, Krishna Y, Dixon S, Haridas A, Grierson I, Sheridan C: Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J Mater Sci Mater Med 2005; 16: 1087-1092.
136. Da Silva GR, Da Silva-Cunha A Jr, Vieira LC, Silva LM, Ayres E, Orefice RL, Fialho SL, Saliba JB, Behar-Cohen F: Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth. J Mater Sci Mater Med 2013; 24: 1309-1317.
137. Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai YC, Hikita ST, Johnson LV, Clegg DO, Thomas BB, Humayun MS: A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res 2012; 48: 186-191.
138. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, Rajala K, Onnela N, Narkilahti S, Suuronen R, Hyttinen J, Uusitalo H, Skottman H: Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis 2011; 17: 558-575.
139. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R: Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012; 379: 713-720.
140. Huang J, McAlinden C, Wang Q, Jin ZB, Pesudovs K: Embryonic stem-cellderived retinal pigment epithelial cells for macular degeneration. Lancet 2012; 379: 2050; author reply 2050-2051.